Phase III HOVON97: Azacitidine Maintenance in Older Patients With AML and Refractory Anemia

Slideset - Azacitidine was well tolerated and significantly improved disease-free survival in older patients with anemia-refractory AML.

Source: Clinical Care Options Leukemia - December 18, 2017 Category: Hematology Source Type: research